Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Staphylococcus aureus proteases trigger eosinophil-mediated skin inflammation
  2. Kline, Sabrina N; Orlando, Nicholas A; Lee, Alex J; Wu, Meng-Jen; Zhang, Jing; Youn, Christine; Feller, Laine E; Pontaza, Cristina; Dikeman, Dustin; Limjunyawong, Nathachit; Williams, Kaitlin L; Wang, Yu; Cihakova, Daniela; Jacobsen, Elizabeth A; Durum,Scott; Garza, Luis A; Dong, Xinzhong; Archer, Nathan K
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Feb 06; 121(6): e2309243121.
  1. 2.   Differential expression of Triggering Receptor Expressed on Myeloid cells 2 (Trem2) in tissue eosinophils
  2. Sek, Albert C.; Percopo, Caroline M.; Boddapati, Arun K.; Ma, Michelle; Geslewitz, Wendy E.; Krumholz, Julia O.; Lack,Justin; Rosenberg, Helene F.
  3. Journal of leukocyte biology. 2021, Oct; 110(4): 679-691.
  1. 3.   Single-organ and Multisystem hypereosinophilic syndrome patients with gastrointestinal manifestations share common characteristics
  2. Kuang, Fei Li; Curtin, Bryan F; Alao, Hawwa; Piligian, Brent; Berry, Alexis; Holland-Thomas, Nicole; Powers, Astin; Quezado, Martha; Lumbard,Keith; Fay, Michael P; Klion, Amy D; Kumar, Sheila; Khoury, Paneez
  3. The journal of allergy and clinical immunology. In practice. 2020, SEP; 8: 2718-+.
  1. 4.   Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report
  2. Kim, Doyoung; Kobayashi, Tetsuro; Voisin, Benjamin; Jo, Jay-Hyun; Sakamoto, Keiko; Jin, Seon-Pil; Kelly,Michael; Pasieka, Helena B; Naff, Jessica L; Meyerle, Jon H; Ikpeama, Ijeoma D; Fahle, Gary A; Davis, Fred P; Rosenzweig, Sergio D; Alejo, Julie C; Pittaluga, Stefania; Kong, Heidi H; Freeman, Alexandra F; Nagao, Keisuke
  3. Nature medicine. 2020, Jan 20;
  1. 5.   Novel Peptide Nanoparticle Biased Antagonist of CCR3 Blocks Eosinophil Recruitment and Airway Hyperresponsiveness
  2. Grozdanovic, Milica; Laffey, Kimberly G; Abdelkarim, Hazem; Hitchinson, Ben; Harijith, Anantha; Moon, Hyung-Geon; Park, Gye Young; Rousslang, Lee K; Masterson, Joanne C; Furuta, Glenn T; Tarasova, Nadya; Gaponenko, Vadim; Ackerman, Steven J
  3. The Journal of allergy and clinical immunology. 2019, Feb; 143(2): 669-680.e12.
  1. 6.   Hypereosinophilic Syndrome Subtype Predicts Responsiveness to Glucocorticoids
  2. Khoury, Paneez; Abiodun, Annalise O; Holland-Thomas, Nicole; Fay, Michael P; Klion, Amy D
  3. Journal of Allergy and Clinical Immunology. In Practice. 2018, JAN-FEB; 6(1): 190-195.
  1. 7.   Dysregulation of interleukin 5 expression in familial eosinophilia.
  2. Prakash Babu, Senbagavalli; Chen, Yun-Yun K; Bonne-Annee, Sandra; Yang, Jun; Maric, Irina; Myers, Timothy G; Nutman, Thomas B; Klion, Amy D
  3. Allergy. 2017, Sep; 72(9): 1338-1345.
  1. 8.   CpG-conjugated apoptotic tumor cells elicit potent tumor-specific immunity
  2. Shirota, H.; Klinman, D. M.
  3. Cancer Immunology Immunotherapy. 2011, May; 60(5): 659-669.
  1. 9.   The alarmin functions of high-mobility group proteins
  2. Yang, D.; Tewary, P.; de la Rosa, G.; Wei, F.; Oppenheim, J. J.
  3. Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms. 2010, Jan-Feb; 1799(1-2): 157-163.
  1. 10.   Alarmins initiate host Defense
  2. Oppenheim, J. J.; Tewary, P.; de la Rosa, G.; Yang, D.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 185-194.
  1. 11.   High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin
  2. Yang, D.; Chen, Q.; Yang, H.; Tracey, K. J.; Bustin, M.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2007, Jan; 81(1): 59-66.
  1. 12.   Involvement of galectin-9 in guinea pig allergic airway inflammation
  2. Yamamoto, H.; Kashio, Y.; Shoji, H.; Shinonaga, R.; Yoshimura, T.; Nishi, N.; Nabe, T.; Nakamura, T.; Kohno, S.; Hirashima, M.
  3. International Archives of Allergy and Immunology. 2007 143: 95-105.
  1. 13.   Defensin participation in innate and adaptive immunity
  2. Yang, D.; Liu, Z. H.; Tewary, P.; Chen, Q.; De la Rosa, G.; Oppenheim, J. J.
  3. Current Pharmaceutical Design. 2007 13(30): 3131-3139.
  1. 14.   Ribonucleases in HIV type 1 inhibition: Effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression
  2. Bedoya, V. I.; Boasso, A.; Hardy, A. W.; Rybak, S.; Shearer, G. M.; Rugeles, M. T.
  3. Aids Research and Human Retroviruses. 2006, Sep; 22(9): 897-907.
  1. 15.   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
  2. Kurosaka, K.; Chen, Q.; Yarovinsky, F.; Oppenheim, J. J.; Yang, D.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6257-6265.
  1. 16.   IFN-gamma gene expression is controlled by the architectural transcription factor HMGA1
  2. Chau, K. Y.; Keane-Myers, A. M.; Fedele, M.; Ikeda, Y.; Creusot, R. J.; Menozzi, L.; Cousins, D. J.; Manfioletti, G.; Feigenbaum, L.; Fusco, A.; Ono, S. J.
  3. International Immunology. 2005, MAR; 17(3): 297-306.
  1. 17.   Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation
  2. Yang, D.; Chen, Q.; Rosenberg, H. F.; Rybak, S. M.; Newton, D. L.; Wang, Z. Y.; Fu, Q.; Tchernev, V. T.; Wang, M. J.; Schweitzer, B.; Kingsmore, S. F.; Patel, D. D.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Journal of Immunology. 2004, NOV 15; 173(10): 6134-6142.
  1. 18.   Eosinophil-derived neurotoxin (EDN) is a selective chemoattractant and activator of dendritic cells
  2. Yang, D.; Chen, Q.; Kurosaka, K.; Howard, O. M. Z.; Rosenberg, H. F.; Rybak, S. M.; Kingsmore, S. F.; Oppenheim, J. J.
  3. Faseb Journal. 2004 18(5, Suppl. S): A1144-A1144.
  1. 19.   Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense
  2. Yang, D.; Biragyn, A.; Hoover, D. M.; Lubkowski, J.; Oppenheim, J. J.
  3. Annual Review of Immunology. 2004 22: 181-215.
  1. 20.   Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition
  2. Rugeles, M. T.; Trubey, C. A.; Bedoya, V. I.; Pinto, L. A.; Oppenheim, J. J.; Rybak, S. A.; Shearer, G. M.
  3. Aids. 2003 17(4): 481-486.
  1. 21.   Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3(+) endothelial cells
  2. Salcedo, R.; Young, H. A.; Ponce, M. L.; Ward, J. M.; Kleinman, H. K.; Murphy, W. J.; Oppenheim, J. J.
  3. Journal of Immunology. 2001 166(12): 7571-7578.
  1. 22.   Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses
  2. Chertov, O.; Yang, D.; Howard, O. M. Z.; Oppenheim, J. J.
  3. Immunological Reviews. 2000 177: 68-78.
  1. 23.   International union of pharmacology. XXII. Nomenclature for chemokine receptors
  2. Murphy, P. M.; Baggiolini, M.; Charo, I. F.; Hebert, C. A.; Horuk, R.; Matsushima, K.; Miller, L. H.; Oppenheim, J. J.; Power, C. A.
  3. Pharmacological Reviews. 2000 52(1): 145-176.
  1. 24.   Anti-inflammatory actions of interleukin-13 - Suppression of tumor necrosis factor-alpha and antigen-induced leukocyte accumulation in the guinea pig lung
  2. Watson, M. L.; White, A. M.; Campbell, E. M.; Smith, A. W.; Uddin, J.; Yoshimura, T.; Westwick, J.
  3. American Journal of Respiratory Cell and Molecular Biology. 1999 20(5): 1007-1012.
  1. 25.   Natural and engineered cytotoxic ribonucleases: Therapeutic potential
  2. Rybak, S. M.; Newton, D. L.
  3. Experimental Cell Research. 1999 253(2): 325-335.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel